| scholarly article | Q13442814 |
| P50 | author | Ian G. Campbell | Q47503141 |
| P2093 | author name string | Darren R Shafren | |
| E Susanne Johansson | |||
| Richard D Barry | |||
| Dianne Sylvester | |||
| P2860 | cites work | Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids | Q35747173 |
| Enterovirus receptors and virus replication in human leukocytes | Q40959404 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 320-328 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Oncolysis of human ovarian cancers by echovirus type 1 | |
| P478 | volume | 115 |
| Q38695916 | Bioselection of coxsackievirus B6 strain variants with altered tropism to human cancer cell lines. |
| Q35541517 | Cytolytic replication of echoviruses in colon cancer cell lines |
| Q92119151 | Developing Picornaviruses for Cancer Therapy |
| Q64124150 | Human Neonatal Fc Receptor Is the Cellular Uncoating Receptor for Enterovirus B |
| Q38972691 | Improved replication efficiency of echovirus 5 after transfection of colon cancer cells using an authentic 5' RNA genome end methodology |
| Q54285609 | Inhibition of PKC-Induced COX-2 and IL-8 Expression in Human Breast Cancer Cells by Glucosamine. |
| Q38715077 | Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas |
| Q40051845 | Oncolytic Viral Therapy for Mesothelioma |
| Q41684403 | Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies. |
| Q35597082 | Oncolytic virotherapy for ovarian cancer |
| Q37818831 | Oncolytic virotherapy of gynecologic malignancies |
| Q38061306 | Oncolytic viruses & their specific targeting to tumour cells |
| Q36769180 | Oncolytic viruses in cancer therapy |
| Q38264443 | Oncolytic viruses in head and neck cancer: a new ray of hope in the management protocol |
| Q38577450 | Oncolytic viruses: a new class of immunotherapy drugs |
| Q45418761 | Pharmacokinetics of oncolytic measles virotherapy: eventual equilibrium between virus and tumor in an ovarian cancer xenograft model |
| Q36315580 | Recent progress in the battle between oncolytic viruses and tumours |
| Q39896049 | Regional administration of oncolytic Echovirus 1 as a novel therapy for the peritoneal dissemination of gastric cancer |
| Q47160989 | Review: Oncolytic virotherapy, updates and future directions |
| Q34707959 | Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers |
| Q26767082 | Therapeutic Use of Native and Recombinant Enteroviruses |
| Q58763072 | Three-dimensional tumor cell cultures employed in virotherapy research |
| Q36850878 | Viruses as anticancer drugs |
| Q38170360 | β1 integrin: Critical path to antiangiogenic therapy resistance and beyond |
Search more.